EGF and neoplasm: Using this model, we investigated non-autonomous effects of Crol/hZNF267 manipulations in EC and found that >crol boosts ISC tumour cell mass by 4-fold leading to confluent tumours along the midgut (Fig. 6G, J) comparable to tumour-induction by microenvironmentally-derived mitogenic EGF ligands46,56.